Xenetic Biosciences, Inc. (XBIO)
NASDAQ: XBIO · Real-Time Price · USD
4.290
+0.060 (1.42%)
Sep 2, 2026, 1:14 PM EDT - Market open
Xenetic Biosciences Market Cap
Xenetic Biosciences has a market cap or net worth of $10.05 million as of September 2, 2026. Its market cap has increased by 128.46% in one year.
Market Cap
10.05M
Enterprise Value
3.58M
1-Year Change
128.46%
Ranking
Category
Stock Price
$4.29
ChartMarket Cap Chart
Since June 30, 2016, Xenetic Biosciences's market cap has decreased from $47.70M to $10.05M, a decrease of -78.93%. That is a compound annual growth rate of -14.18%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 2, 2026 | 10.05M | 101.04% |
| Dec 31, 2025 | 5.00M | -19.35% |
| Dec 31, 2024 | 6.20M | 16.98% |
| Dec 29, 2023 | 5.30M | 23.26% |
| Dec 30, 2022 | 4.30M | -75.14% |
| Dec 31, 2021 | 17.30M | 35.16% |
| Dec 31, 2020 | 12.80M | 54.22% |
| Dec 31, 2019 | 8.30M | -46.10% |
| Dec 31, 2018 | 15.40M | -7.78% |
| Dec 29, 2017 | 16.70M | -53.09% |
| Dec 30, 2016 | 35.60M | -25.37% |
| Jun 30, 2016 | 47.70M | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Kiora Pharmaceuticals | 11.11M |
| IN8bio | 10.84M |
| CytoMed Therapeutics | 10.75M |
| Azitra | 10.61M |
| Lunai Bioworks | 10.31M |
| Aprea Therapeutics | 10.07M |
| Imunon | 9.15M |
| Traws Pharma | 9.10M |